Benchmark Capital Co-Founder Invests Millions with Leading Cancer Charity to Bring Silicon Valley Venture Capital Approach to Funding Cancer Research at Damon Runyon Cancer Research Foundation

NEW YORK & PALO ALTO, Calif.--(BUSINESS WIRE)--To foster radical breakthroughs in cancer, the Damon Runyon Cancer Research Foundation and Andrew and Debra Rachleff have created a novel grant program to provide seed funding for young scientists to conduct high risk research designed to significantly impact our understanding of cancer and approaches to its prevention, diagnosis and treatment.

MORE ON THIS TOPIC